Advertisement
Loading...

EyePoint Pharmaceuticals, Inc.

EYPT•NASDAQ
Healthcare
Biotechnology
$12.93
$0.15(1.17%)
U.S. Market opens in 1h 36m
Advertisement

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Overview

Explore EyePoint Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E Ratio-4.09
EPS (TTM)$-3.51
ROE-1.11%
Fundamental Analysis

AI Price Forecasts

1 Month$15.48
3 Months$17.56
1 Year Target$14.29

EYPT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of EyePoint Pharmaceuticals, Inc. (EYPT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.04, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.29.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.09 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.17%
5-Day Change
8.20%
1-Month Change
-6.10%
3-Month Change
-27.20%
6-Month Change
-12.28%
Year-to-Date (YTD) Change
-29.23%
1-Year Change
116.95%
3-Year Change
118.04%
5-Year Change
42.40%
All-Time (Max) Change
-96.78%

Contact Information

https://eyepointpharma.com
617 926 5000
480 Pleasant Street, Watertown, MA, 02472

Company Facts

165 Employees
IPO DateJan 27, 2005
CountryUS
Actively Trading

Frequently Asked Questions